Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.31%
0%
-19.31%
6 Months
-16.17%
0%
-16.17%
1 Year
7.69%
0%
7.69%
2 Years
-45.1%
0%
-45.1%
3 Years
-31.71%
0%
-31.71%
4 Years
-47.47%
0%
-47.47%
5 Years
-14.11%
0%
-14.11%
Proteome Sciences Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.07%
EBIT Growth (5y)
-208.01%
EBIT to Interest (avg)
-0.27
Debt to EBITDA (avg)
7.03
Net Debt to Equity (avg)
-1.90
Sales to Capital Employed (avg)
0.67
Tax Ratio
4.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.37%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.67
EV to EBIT
-8.85
EV to EBITDA
-13.86
EV to Capital Employed
3.52
EV to Sales
4.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-39.80%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
5.00
7.80
-35.90%
Operating Profit (PBDIT) excl Other Income
-1.00
1.90
-152.63%
Interest
0.80
0.50
60.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.40
1.30
-284.62%
Operating Profit Margin (Excl OI)
-292.40%
191.50%
-48.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -35.90% vs 52.94% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -284.62% vs 1,200.00% in Dec 2022
About Proteome Sciences Plc 
Proteome Sciences Plc
Pharmaceuticals & Biotechnology
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Company Coordinates 
Company Details
Hamilton House, Mabledon Place , LONDON None : WC1H 9BB
Registrar Details






